Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Assets: 2009-2024

Historic Assets for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $7.4 billion.

  • UNITED THERAPEUTICS's Assets rose 3.20% to $7.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 billion, marking a year-over-year increase of 3.20%. This contributed to the annual value of $7.4 billion for FY2024, which is 2.75% up from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Assets is $7.4 billion, which was up 2.75% from $7.2 billion recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Assets high stood at $7.4 billion for FY2024, and its period low was $4.6 billion during FY2020.
  • Its 3-year average for Assets is $6.9 billion, with a median of $7.2 billion in 2023.
  • Data for UNITED THERAPEUTICS's Assets shows a peak YoY climbed of 18.57% (in 2023) over the last 5 years.
  • UNITED THERAPEUTICS's Assets (Yearly) stood at $4.6 billion in 2020, then climbed by 12.01% to $5.2 billion in 2021, then increased by 16.94% to $6.0 billion in 2022, then increased by 18.57% to $7.2 billion in 2023, then rose by 2.75% to $7.4 billion in 2024.